•
Dec 31, 2019

Ecolab Q4 2019 Earnings Report

Ecolab's Q4 2019 earnings were released, showcasing an 8% increase in adjusted diluted earnings per share, driven by better pricing, new business gains, product innovation, and cost efficiencies, which offset investments and a Healthcare product recall.

Key Takeaways

Ecolab reported a 2% increase in sales and an 8% increase in adjusted diluted earnings per share for Q4 2019. The company's performance was driven by pricing, lower product costs, and cost efficiency actions, which offset investments and a Healthcare product recall. The company expects another strong earnings year in 2020, despite a challenging environment.

Reported diluted EPS increased by 9% to $1.47.

Adjusted diluted EPS grew by 8% to $1.66, excluding special gains, charges, and discrete tax items.

Acquisition adjusted fixed currency sales increased by 1%, with growth in Industrial, Institutional, and Other segments offset by a 3% decline in Energy.

Adjusted fixed currency operating margin expanded by 60 bps, driven by double-digit income growth in Industrial and Energy segments.

Total Revenue
$3.82B
Previous year: $3.76B
+1.7%
EPS
$1.69
Previous year: $1.54
+9.7%
Operating Income Margin
14.7%
Gross Profit
$1.61B
Previous year: $1.54B
+4.0%
Cash and Equivalents
$119M
Previous year: $63.9M
+85.9%
Free Cash Flow
$571M
Previous year: $614M
-7.1%
Total Assets
$20.9B
Previous year: $20.1B
+4.0%

Ecolab

Ecolab

Ecolab Revenue by Segment

Forward Guidance

Ecolab expects full year 2020 adjusted diluted earnings per share in the $6.33 to $6.53 range, rising 9% to 12% over 2019. This forecast includes an estimated unfavorable $0.05 per share impact from the effects of the coronavirus outbreak in the first quarter.

Positive Outlook

  • Improving volume gains and continued pricing benefit sales.
  • Improving adjusted gross margin reflecting volume gains, pricing, flattish delivered product costs and cost efficiency actions.
  • Lower SG&A ratio to sales.
  • A similar adjusted tax rate versus 2019.
  • Strong underlying new business momentum and innovation pipeline.

Challenges Ahead

  • An estimated unfavorable $0.05 per share impact from the effects of the coronavirus outbreak in the first quarter.
  • Lower other income as lower interest rates result in unfavorable pension expense.
  • Higher interest expense.
  • Currently quantifiable special charges in 2020 to be $0.45 to $0.55 per share.
  • Foreign currency translation to have an unfavorable $0.04 impact on full year diluted earnings per share.

Revenue & Expenses

Visualization of income flow from segment revenue to net income